JAK2 inhibition sensitizes resistant EGFR-mutant lung adenocarcinoma to tyrosine kinase inhibitors

Lung adenocarcinomas with mutant epidermal growth factor receptor (EGFR) respond to EGFR-targeted tyrosine kinase inhibitors (TKIs), but resistance invariably occurs. We found that the Janus kinase (JAK)/signal transduction and activator of transcription 3 (STAT3) signaling pathway was aberrantly in...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Sci Signal
Huvudupphovsmän: Gao, Sizhi P., Chang, Qing, Mao, Ninghui, Daly, Laura A., Vogel, Robert, Chan, Tyler, Liu, Shu Hui, Bournazou, Eirini, Schori, Erez, Zhang, Haiying, Brewer, Monica Red, Pao, William, Morris, Luc, Ladanyi, Marc, Arcila, Maria, Manova-Todorova, Katia, de Stanchina, Elisa, Norton, Larry, Levine, Ross L., Altan-Bonnet, Gregoire, Solit, David, Zinda, Michael, Huszar, Dennis, Lyden, David, Bromberg, Jacqueline F.
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2016
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4950506/
https://ncbi.nlm.nih.gov/pubmed/27025877
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/scisignal.aac8460
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk